The E2A-HLF oncogenic fusion protein acts through Lmo2 and Bcl-2 to immortalize hematopoietic progenitorsJasper de Boer, Hugh J.M. Brady, Beat Bornhäuser et al.|Leukemia|2010Cited by 42
Clinical utility of vinblastine therapeutic drug monitoring for the treatment of infantile myofibroma patients: A case seriesVickyanne Carruthers, Gareth J. Veal, S. Barnett et al.|Pediatric Blood & Cancer|2022Cited by 4